STC2 Antibodies

Santa Cruz Biotechnology delivers a wide array of STC2 Antibodies for investigating the role of STC2 protein. STC2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STC2, or Stanniocalcin 2, is a glycoprotein that plays a critical role in calcium and phosphate homeostasis, as well as in cellular responses to stress. STC2 has been implicated in various physiological processes, including bone metabolism and the regulation of cell survival. Research has shown that STC2 expression levels can vary significantly in different tissue types and under various physiological conditions. Understanding STC2 function is essential for elucidating its involvement in diseases such as cancer and metabolic disorders. Ongoing studies continue to reveal new insights about STC2's role in cellular signaling pathways and tissue development. Current research suggests that STC2 may serve as a potential therapeutic target for various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of STC2's biological functions and potential therapeutic applications.